(Q40082232)

17 September 2017

1 reference

title

The pathophysiology of extrapyramidal side-effects of neuroleptic drugs (English)

1 reference

17 September 2017

1 reference

1

Marsden CD

1 reference

17 September 2017

C. D. Marsden

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6104342

6 August 2023

P. Jenner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6104342

6 August 2023

language of work or name

English

0 references

publication date

1 February 1980

1 reference

full work available at URL

17 September 2017

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S003329170003960X

1 reference

https://api.crossref.org/works/10.1017/S003329170003960X

6 August 2023

published in

Psychological Medicine

1 reference

17 September 2017

10

1 reference

17 September 2017

55-72

1 reference

17 September 2017

1

1 reference

Antipsychotic drugs: clinical pharmacology and therapeutic use.

17 September 2017

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Interaction between cholinergic and catecholaminergic neurones in rat brain.

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Excitation-mediating and inhibition-mediating dopamine-receptors: A new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Changes in dopamine-mediated behaviour during one year's neuroleptic administration

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

On the supersensitivity of dopamine receptors, induced by neuroleptics

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Paradoxical response to dopamine agonists in tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Histochemical confirmation for dopaminergic innervation of the rat cerebral cortex after destruction of the noradrenergic ascending pathways.

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

A survey of drug-induced extrapyramidal reactions

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Adrenergic mechanisms

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Persistent Dyskinesia

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Dopamine receptors: selective agonists and antagonists of functionally distinct types within the feline brain

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Postsynaptic receptors are not essential for dopaminergic feedback regulation

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Influence of flupenthixol and flupenthixol-decanoate on methylphenidate and apomorphine-induced compulsive gnawing in mice

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Release of dopamine from dendrites in rat substantia nigra

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine.

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Psychotherapy and pharmacotherapy in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Aromatic Amino Acids and Modification of Parkinsonism

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Dopamine turnover in the corpus striatum and the lumbic system after treatment with neuroleptic and anti-acetylcholine drugs.

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six months

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Intranigral kainic acid: evidence for nigral non-dopaminergic neurons controlling posture and behavior in a manner opposite to the dopaminergic ones

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Dystonic reactions following neuroleptics: Time Course and proposed mechanisms

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

d -Amphetamine-Induced Inhibition of Central Dopaminergic Neurons: Mediation by a Striato-Nigral Feedback Pathway

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Biochemical evidence for the presence of presynaptic receptors on dopaminergic nerve terminals

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Pharmacokinetics of red blood cell phenothiazine and clinical effects. Acute dystonic reactions

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Neuroleptic antagonism of dyskinetic phenomena

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Self-inhibition by Dopaminergic Neurons

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Mesencephalic dopamine neurons projecting to neocortex.

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Release of dopamine in vivo from cat substantia nigra.

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Letter: Chorea and torsion in parkinsonism

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the frontocortical dopaminergic innervation in the rat

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Bromocriptine in Parkinsonism.

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Does dopamine play a role in schizophrenia?

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Evidence for dopamine receptors mediating sedation in the mouse brain

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

A study of supersensitivity in denervated mammalian skeletal muscle

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Adrenergic Effect of Chronic Administration of Neuroleptics

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Pharmaco-histochemical evidence of the existence of dopamine nerve terminals in the limbic cortex.

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Destruction of post-synaptic dopamine receptors prevents neuroleptic-induced activation of striatal tyrosine hydroxylase but not dopamine synthesis stimulation

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Brain receptors for antipsychotic drugs and dopamine: direct binding assays

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Physiologic and clinical effects of chlorpromazine and their relationship to plasma level

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Antagonism by haloperidol of locomotor depression induced by small doses of apomorphine

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Effects of small doses of haloperidol on timing behavior

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Drug-induced changes in the release of 3 H-monoamines from field stimulated rat brain slices.

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Levodopa in drug-induced extrapyramidal disorders

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Feedback loop or output pathway in striato-nigral fibres?

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Relationship between tardive dyskinesia, l-Dopa-induced hyperkinesia and parkinsonism

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

The relationship between parkinsonism and tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Acceleration of turnover of14C-catecholamines in rat brain by chlorpromazine

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Nicotinic effect of acetylcholine on the release of newly synthesized [3H]dopamine in rat striatal slices and cat caudate nucleus

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Presynaptic effect of L-glutamic acid on the release of dopamine in rat striatal slices

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Inhibition by dopamine agonists of dopamine accumulation following γ-hydroxybutyrate treatment

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Single and repeated administration of neuroleptic drugs to rats: Effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-dopa

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Dopamine-receptor binding and adenylate-cyclase activity in mouse striatal tissue in the supersensitivity phase after neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

The effect of surgical lesions to frontal cortex and substantia nigra on amphetamine responses in rats

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

An experimental model of tardive dyskinesias

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Trial of Maintenance Therapy in Schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Interactions of orphenadrine and phenobarbitone with chlorpromazine: plasma concentrations and effects in man

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Long-term changes in the sensitivity of pre-and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Acute dystonia as an idiosyncratic response to neuroleptics in baboons

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Effect of drugs used in psychoses on cerebral dopamine metabolism

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Amphetamine-induced release of dopamine from the substantia nigra in vitro

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Localization of dopamine receptors in rat brain

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Striatal adenylate cyclase activity following reserpine and chronic chlorpromazine administration in rats

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Dopamine-sensitive adenylate cyclase in homogenates of rat striata during ethanol and barbiturate withdrawal

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Localization of Nigral Dopamine-Sensitive Adenylate Cyclase on Neurons Originating from the Corpus Striatum

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Dopaminergic Terminals in the Rat Cortex

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Midification of tardive dyskinesia and spasmodic torticollis by apomorphine. Possible role of dopamine autoreceptors

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Movement disorders induced in monkeys by chronic haloperidol treatment

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Effect of cholinergic and anticholinergic agents on tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Multiple receptors for dopamine

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Further studies on the accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain. Effect of some phenothiazine analogues

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase.

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Effects of dopamine agonists in tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Haloperidol-induced tardive dyskinesia in monkeys

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Dopamine ?Autoreceptors?: Pharmacological characterization by microiontophoretic single cell recording studies

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

The pharmacology of tardive dyskinesias

1 reference

https://api.crossref.org/works/10.1017%2FS003329170003960X

7 January 2021

Regulation of monoamine metabolism in the central nervous system

10

1 reference

https://api.crossref.org/works/10.1017/S003329170003960X

Effect of thioridazine, clozapine and other antipsychotics on the kinetic state of tyrosine hydroxylase and on the turnover rate of dopamine in striatum and nucleus accumbens

6 August 2023

19

1 reference

https://api.crossref.org/works/10.1017/S003329170003960X

TIME COURSE OF CHANGES IN SENSITIVITY AFTER DENERVATION OF THE NICTITATING MEMBRANE OF THE SPINAL CAT

6 August 2023

44

1 reference

https://api.crossref.org/works/10.1017/S003329170003960X

Haloperidol-Induced Dyskinesias in the Monkey

6 August 2023

81

1 reference

https://api.crossref.org/works/10.1017/S003329170003960X

The onset of denervation supersensitivity

6 August 2023

89

1 reference

https://api.crossref.org/works/10.1017/S003329170003960X

Epidemiology of tardive dyskinesia. Part II

6 August 2023

98

1 reference

https://api.crossref.org/works/10.1017/S003329170003960X

Controlled studies of antiparkinsonism agents in the treatment of drug-induced extrapyramidal sympttoms

6 August 2023

115

1 reference

https://api.crossref.org/works/10.1017/S003329170003960X

Supersensitivity and subsensitivity to sympathomimetic amines

6 August 2023

126

1 reference

https://api.crossref.org/works/10.1017/S003329170003960X

Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment

6 August 2023

129

1 reference

https://api.crossref.org/works/10.1017/S003329170003960X

6 August 2023

Identifiers

0 references

1 reference